Literature DB >> 8655924

Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis.

M Provinciali1, G Di Stefano, M Muzzioli, G G Garzetti, A Ciavattini, N Fabris.   

Abstract

Endometriosis is an estrogen-dependent disease affecting women during their reproductive years. An abnormal immune function and, in particular, a decreased natural killer (NK) cell activity have been found in endometriosis, suggesting a role of the immune system in the pathophysiology of the disease. We have recently evidenced a significant inverse relationship between 17-beta-estradiol plasma levels and NK cytotoxicity in endometriosis patients. In this study we have investigated the combined role of 17-beta-estradiol (E2) and prolactin (PRL) in the regulation of NK cell activity during the progression of endometriosis, by evaluating the correlation among E2, PRL, and other immunomodulating neurohormones on both the cytotoxic activity and the number of NK cells in women at different stages of endometriosis. The early stages (I/II) of endometriosis are characterized by increased plasma levels of either E2 or PRL without significant alterations of NK cell activity in comparison with healthy subjects. The progression to advanced stages (III/IV) of the disease is associated with a further increase of E2 levels, a decrease of PRL plasma concentrations (with an increase of E2/PRL ratio), and an impairment of NK cytotoxicity. The plasma levels of both E2 and PRL and the E2/PRL ratio are significantly correlated with the values of NK cytotoxicity in advanced stages of endometriosis. Either the absolute number or the relative percentage of CD16+ or CD56+ peripheral lymphocytes are not significantly different between patients at either stages I/II or III/IV and healthy controls. Plasma levels of progesterone (P) and luteinizing hormone (LH), are not significantly changed in different stages of endometriosis with respect to healthy controls. The significant decrease of follicle-stimulating hormone (FSH) plasma levels found in either stages I/II or III/IV endometriosis patients is not correlated with the NK cell activity. In conclusion, at advanced stages of endometriosis the impairment of NK cell activity occurs with increased E2, and decreased PRL plasma levels. Additional studies are required to determine whether the E2/PRL ratio represents a possible biochemical marker of endometriosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655924     DOI: 10.1007/bf03349783

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Etiology and epidemiology of endometriosis.

Authors:  R L Barbieri
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

Review 2.  Production and differentiation of NK linkage cells in bone marrow.

Authors:  S B Pollack
Journal:  Nat Immun       Date:  1993 Jul-Oct

3.  Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium.

Authors:  D J Oosterlynck; F J Cornillie; M Waer; M Vandeputte; P R Koninckx
Journal:  Fertil Steril       Date:  1991-07       Impact factor: 7.329

4.  Natural killer activity in hyperprolactinemic patients.

Authors:  L Matera; E Ciccarelli; A Cesano; F Veglia; C Miola; F Camanni
Journal:  Immunopharmacology       Date:  1989 Sep-Oct

5.  Nocturnal prolactin levels in infertile women with endometriosis.

Authors:  E Radwanska; I Henig; W P Dmowski
Journal:  J Reprod Med       Date:  1987-08       Impact factor: 0.142

6.  Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity.

Authors:  G G Garzetti; A Ciavattini; M Provinciali; N Fabris; M Cignitti; C Romanini
Journal:  Obstet Gynecol       Date:  1993-05       Impact factor: 7.661

7.  Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A.

Authors:  L Matera; G Muccioli; A Cesano; G Bellussi; E Genazzani
Journal:  Brain Behav Immun       Date:  1988-03       Impact factor: 7.217

8.  Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay.

Authors:  M Provinciali; G Di Stefano; N Fabris
Journal:  J Immunol Methods       Date:  1992-10-19       Impact factor: 2.303

9.  Estrogen and progestin receptors in endometriosis lesions: comparison with endometrial tissue.

Authors:  O Jänne; A Kauppila; E Kokko; T Lantto; L Rönnberg; R Vihko
Journal:  Am J Obstet Gynecol       Date:  1981-11-01       Impact factor: 8.661

10.  Prolactin and its response to the luteinizing hormone-releasing hormone thyrotropin-releasing hormone test in patients with endometriosis before, during, and after treatment with danazol.

Authors:  P Acién; M Lloret; M Graells
Journal:  Fertil Steril       Date:  1989-05       Impact factor: 7.329

View more
  5 in total

Review 1.  Trafficking of peripheral blood CD56(bright) cells to the decidualizing uterus--new tricks for old dogmas?

Authors:  Marianne van den Heuvel; Crystal Peralta; Siamak Bashar; Suzanne Taylor; Julie Horrocks; B Anne Croy
Journal:  J Reprod Immunol       Date:  2005-08-16       Impact factor: 4.054

Review 2.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production.

Authors:  W Walker; C W Roberts; D J Ferguson; H Jebbari; J Alexander
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Immune interactions in endometriosis.

Authors:  Jennifer L Herington; Kaylon L Bruner-Tran; John A Lucas; Kevin G Osteen
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

5.  Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy
Journal:  Int J Womens Health       Date:  2012-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.